Identification of pharmacophores for anti-inflammatory and analgesic activity on aryl-(imidazol-1-yl) acetates
Rajesh Sharma, Parvathi Rao, Shashank Chaturvedi
Abstract
Rajesh Sharma, Parvathi Rao, Shashank Chaturvedi
Abstract
Rofecoxib being a selective cyclooygenase-2 inhibitor has been banned as a non-steroidal anti-inflammatory drug. This has opened new opportunities in the field of research and development of non steroidal anti-inflammatory drugs. In this search, pharmacophores for anti-inflammatory and analgesic activity based on aryl-(imidazol-l-yl) acetates have been identified.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Rofecoxib being a selective cyclooygenase-2 inhibitor has been banned as a non-steroidal anti-inflammatory drug. This has opened new opportunities in the field of research and development of non steroidal anti-inflammatory drugs. In this search, pharmacophores for anti-inflammatory and analgesic activity based on aryl-(imidazol-l-yl) acetates have been identified.
Key concepts: Pharmacophore, Anti-inflammatory, Analgesic, Aryl, Pharmacology, Drug, Chemistry, Analgesic agents